Diagnostic method for biomarkers of adverse coronary events
US8137978B2 · kind B2 · utility
1Cited by
1References
18Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Oct 16, 2009 |
| Grant date | Mar 20, 2012 |
| Priority date | — |
| Expiry date | May 27, 2030 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY10T436/203332
- WIPO fieldMeasurement
- WIPO sectorInstruments
Abstract
A diagnostic method using biomarkers to predict future adverse coronary events is provided. More particularly, the present invention is directed to diagnostic tests for characterizing an individual's risk of developing or having cardiovascular disease. In certain embodiments, the method of the present invention quantitates the presence of elevated levels of chlorinated lipids derived from myeloperoxidase as a prognostic indicator of future adverse coronary events.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.